14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALDR
Delisted

Alder BioPharmaceuticals Stock Price (Quote)

$18.88
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 15th Apr 2020 ALDR stock ended at $18.88. During the day the stock fluctuated 0% from a day low at $18.88 to a day high of $18.88.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Alder BioPharmaceuticals prices

Date Open High Low Close Volume
Apr 17, 2019 $13.71 $13.74 $12.71 $12.78 1 057 037
Apr 16, 2019 $13.04 $13.68 $12.84 $13.63 877 692
Apr 15, 2019 $13.28 $13.30 $12.81 $12.95 369 750
Apr 12, 2019 $12.61 $13.28 $12.45 $13.22 1 563 351
Apr 11, 2019 $13.16 $13.26 $12.55 $12.60 757 657
Apr 10, 2019 $13.37 $13.46 $13.05 $13.16 955 749
Apr 09, 2019 $13.89 $14.25 $13.25 $13.34 1 173 428
Apr 08, 2019 $13.89 $14.04 $13.54 $13.90 1 276 034
Apr 05, 2019 $13.47 $13.92 $13.28 $13.86 1 465 497
Apr 04, 2019 $13.96 $14.13 $13.25 $13.33 470 206
Apr 03, 2019 $14.32 $14.39 $13.81 $14.01 985 972
Apr 02, 2019 $13.57 $14.21 $13.37 $14.14 726 188
Apr 01, 2019 $13.77 $13.99 $13.50 $13.60 633 713
Mar 29, 2019 $13.44 $13.66 $13.23 $13.65 625 553
Mar 28, 2019 $13.11 $13.35 $12.93 $13.31 551 676
Mar 27, 2019 $13.40 $13.42 $12.97 $13.07 507 279
Mar 26, 2019 $13.39 $13.50 $13.06 $13.44 481 314
Mar 25, 2019 $12.98 $13.25 $12.50 $13.25 603 371
Mar 22, 2019 $14.06 $14.21 $12.87 $12.95 912 058
Mar 21, 2019 $13.45 $14.91 $13.22 $14.31 2 015 296
Mar 20, 2019 $13.79 $13.79 $13.19 $13.46 693 822
Mar 19, 2019 $13.84 $13.94 $13.65 $13.78 764 192
Mar 18, 2019 $13.50 $13.85 $13.49 $13.71 493 129
Mar 15, 2019 $13.67 $13.91 $13.31 $13.51 1 614 883
Mar 14, 2019 $13.03 $13.74 $13.01 $13.58 741 724
Click to get the best stock tips daily for free!

About Alder BioPharmaceuticals

Alder BioPharmaceuticals Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The company’s lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla... ALDR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT